Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study

Table 2 Categories for assessment of individual risk factors, therapeutic drug monitoring and overall assessment

	Individual RF^aand TDM^b		Assessment of overall treatment quality
	Assessment	Explanation	Assessment	Explanation
1	No need for intervention	Values^d according to references in more than 2/3 of available values; Values better at discharge than at admission; Disease/RF^a is treated; no severe pDDIs^c	Very good RF^a management	No improvements necessary
2	Improvement possible	Values^d outside of reference range in more than 1/3 of available values; Values worse at discharge; severe pDDIs^c; RF is treated	Good RF^a management	Up to two individual RFs^a being assessed as "improvement possible" (category 2); no untreated RFs^a (category 3)
3	Disease untreated	No drug therapy for RF^a treatment; no TDM performed, although appropriate	Improvement in RF^a management needed	More than two individual RFs^a or TDMs^b being assessed as "improvement possible" (category 2) or untreated RF^a (category 3)
4	No conclusion possible	Missing data; inconclusive data	No conclusion possible	Missing data; inconclusive data

^a RF = risk factor
^b TDM = therapeutic drug monitoring
^c pDDI = potential drug-drug interaction
^d e.g., blood pressure, fasting blood glucose, lipid levels, plasma levels of immunosuppressants